Press release
Hepatitis - B Therapeutics Market Global Industry Analysis, Trends and Forecast, 2016-2026
Hepatitis is a serious and common infectious disease which causes inflammation of liver, and can be caused by variety of different viruses such as A, B, C, D and E. Jaundice is a characteristic feature of liver disease. Hepatitis-B is a contagious liver disease which is results from infection with the Hepatitis-B virus (HBV), which is containing a partially double stranded and circular DNA. The virus interfers with hepatocytes, the liver became inflamed. HBV is transmitted through parenteral contact through body fluids, blood, and sexual intercourse. HBV does not able to cross skin or mucous membrane. People with Acquired Immuno Deficiency Syndrome (AIDS), Lymph proliferative disease, and people who are treated with Immuno suppressive drugs and hemodialysis patients are easily develops infection with Hepatitis-B Virus. There are two types of HBV infection Acute and Chronic. Acute Hepatitis B is initial six months of infected with HBV. After certain treatment also the infection remains in human body and leads to a “chronic hepatitis”. There is no treatment for acute hepatitis B.
Hepatitis - B Therapeutics Market: Drivers and restraints
Global Hepatitis - B Therapeutics market can be driven by following drivers, According to the World Health Organization (WHO), Chronic HBV infection occurs majority of the infants, increasing prevalence of Hepatitis-B virus is major driver of the market. The prevalence rate of hepatitis B is increasing gradually, thus propels the Hepatitis B therapeutics market over the forecast period. There are less number of antibiotics are available in the market only antivirals are effectively fight with the HBV. Treatment and medications are highly expensive. These are major bottlenecks for Hepatitis B therapeutics Market.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1224
Hepatitis - B Therapeutics Market: Segmentation
Global Hepatitis - B Therapeutics Market can be segmented as following types
Global Hepatitis - B Therapeutics market by Products:
By Product
Hepatitis B vaccine
Anti-Viral Drugs
Lamivudine
Famciclovir
Acyclovir
Fascornet
Adefovir
Entecavir
Telbivudine
Tenofovir
By Distribution Channel
Hospitals Pharmacies
Pharmacies and Drug Stores
Clinics
Hepatitis - B Therapeutics Market: Overview
Increasing the demand for advanced technological treatments and novel drug products to treat various rare diseases are provides a robust market growth. According Centers for Disease Prevention and Control (CDC), Approximately 1.4 Million patients in the United States are chronically infected with Hepatitis B Virus and the prevalence of hepatitis B virus is high European region followed by United States. The Hepatitis B vaccination and advanced treatment methods to treat Hepatitis B Virus propels Hepatitis - B Therapeutics market over the forecast period.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1224
Hepatitis - B Therapeutics Market: Region-Wise Outlook
Depending upon the geographic regions Hepatitis - B Therapeutics market is segmented into seven key regions: Those are North America, Latin America, and Western Europe, Eastern Europe, and Asia pacific excluding japan, Middle East and Africa (MEA), Japan.
North America dominating the global Hepatitis - B Therapeutics market followed by Europe. Increasing awareness among the people towards the use of novel products and technologies to treat the HBV providing lucrative market. Asian Pacific region market is considered to rapidly evolving healthcare infrastructure and research and development, this region is anticipating providing a robust growth of global Hepatitis - B Therapeutics market over the forecast period.
Hepatitis - B Therapeutics Market: Key players
Some of the key players in Market are GlaxoSmithKline, plc. Bristol-Myers Squibb, Hoffmann- La Roche, Novartis AG, Merck and Co.
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
Future Market Insights
616 Corporate Way,
Suite 2-9018,
Valley Cottage,
New York 10989,
United States
Tel: +1-347-918-3531
Fax: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis - B Therapeutics Market Global Industry Analysis, Trends and Forecast, 2016-2026 here
News-ID: 331494 • Views: …
More Releases from FMI Reports
Research report covers the Triallyl Isocyanurate Market Growth, 2016-2026
Future Market Insights has announced the addition of the “Triallyl Isocyanurate Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Triallyl isocyanurate is used as a cross linking in the manufacture of agrochemicals, flame retardants and synthetic rubbers. It is synthesized by gradually adding cyanuric chloride to excess of alcohol or allyl chloride in the presence concentrated aqueous phase. For various applications, triallyl isocyanurate can be…
Structured Cabling Market Growth and Segments,2016-2026
Future Market Insights has announced the addition of the “Structured Cabling Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Structured cabling system is defined as the combination of set of cables & associated hardware used to provide comprehensive telecommunication infrastructure to various management systems, this telecommunication infrastructure enables the transmission of data, voice & video signal through a communication network from one point to other…
Polyetheramine Market, 2016-2026 by Segmentation: Based on Product, Based on App …
Future Market Insights has announced the addition of the “Polyetheramine Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Polyetheramines are typically the curing agents which contain polyether and amine moieties, are majorly used to increase toughness, flexibility, hydrophobicity or hydrophilicity of the end-products. Polyetheramines are used for a range of applications including polyurea, epoxy curing and polyamides in a range of coatings. Polyetheramines are also…
Immunochemistry Analyzer Market Regulations and Competitive Landscape Outlook to …
Future Market Insights has announced the addition of the “Immunochemistry Analyzer Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.
Immunochemistry analyzer are becoming more and more popular in the global clinical chemistry and immunoassay as these are proved to be very effective tool to diagnose cancer, hepatitis, illegal drugs, fertility problems, sodium levels, endocrine function, and the detection of blood clots.
There are approximately more than 180,000 immunochemistry…
More Releases for Hepatitis
Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available…
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and…
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot
The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
